GRAPHITE BIO INC's ticker is GRPH and the CUSIP is 38870X104. A total of 65 filers reported holding GRAPHITE BIO INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $453,248 | -34.7% | 191,244 | -27.2% | 0.36% | -35.0% |
| Q2 2023 | $693,945 | +1.4% | 262,858 | -6.7% | 0.55% | +1.3% |
| Q1 2023 | $684,679 | -66.3% | 281,761 | -54.0% | 0.54% | -65.1% |
| Q4 2022 | $2,033,517 | +13.5% | 612,505 | +8.4% | 1.54% | -32.5% |
| Q3 2022 | $1,791,000 | +88.9% | 564,946 | +64.0% | 2.28% | +112.8% |
| Q2 2022 | $948,000 | – | 344,567 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 8,459,314 | $20,979,099 | 6.42% |
| OUP Management Co., LLC | 406,308 | $1,007,644 | 2.27% |
| Prosight Management, LP | 1,337,826 | $3,317,808 | 1.05% |
| EcoR1 Capital, LLC | 8,538,446 | $21,175,346 | 0.71% |
| TANG CAPITAL MANAGEMENT LLC | 2,016,626 | $5,001,232 | 0.71% |
| Privium Fund Management (UK) Ltd | 191,244 | $453,248 | 0.36% |
| Newtyn Management, LLC | 542,637 | $1,345,740 | 0.33% |
| Aldebaran Capital, LLC | 130,000 | $322,400 | 0.33% |
| Acuitas Investments, LLC | 195,762 | $485,490 | 0.28% |
| CHI Advisors LLC | 230,938 | $572,726 | 0.23% |